Gilead Sciences (GILD) Gross Profit (2009 - 2026)

Gilead Sciences has reported Gross Profit for 18 years, with the latest figure at $5.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 7.57% year-over-year to $5.5 billion; the trailing twelve-month figure through Mar 2026 stood at $23.6 billion (up 4.89% YoY), and the FY2025 full-year result was $23.2 billion, up 3.14% from the prior year.
• Gross Profit for Q1 2026 stood at $5.5 billion, down from $6.3 billion in the prior quarter.
• The five-year high for Gross Profit was $6.3 billion in Q4 2025, with the low at $4.8 billion in Q2 2022.
• Historically, Gross Profit has averaged $5.5 billion across 5 years, with a median of $5.5 billion in 2023.
• Annual changes were most pronounced in 2022 — Gross Profit grew 29.8% — and 2023, when it declined 16.17%.
• Gilead Sciences' Gross Profit stood at $6.0 billion in 2022, then decreased by 16.17% to $5.0 billion in 2023, then rose by 19.19% to $6.0 billion in 2024, then rose by 5.23% to $6.3 billion in 2025, then slipped by 12.47% to $5.5 billion in 2026.
• The last three Gross Profit figures came in at $5.5 billion (Q1 2026), $6.3 billion (Q4 2025), and $6.2 billion (Q3 2025), per Business Quant data.